KK
Kaushal Kamlesh Shah
About Kaushal Kamlesh Shah
Data last updated:
Kaushal Kamlesh Shah is a Director at Eris Lifesciences Limited (since 2020), Director at Eris Therapeutics Limited (since 2021) and Director at Swiss Parenterals Limited (since 2024), and holds 6 more current directorships. The companies operate in Pharma and Machinery and Equipment. The 6 current companies with reported revenue have a combined latest revenue of ₹6,335 Cr; the largest is Eris Lifesciences Limited at ₹5,069 Cr (FY 2025). Earlier, Kaushal Kamlesh Shah was a Director at Eris Oaknet Healthcare Private Limited (2022) and Director at Eris Therapeutics Private Limited (from 2009) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Eris Lifesciences Limited L24232GJ2007PLC049867 | Director | 04 Aug 2020 | 2007 | ₹5,069 Cr (FY 2025) | Active |
 Eris Therapeutics Limited U24230GJ2021PLC123519 | Director | 23 Jun 2021 | 2021 | ₹771 Cr (FY 2025) | Active |
 Swiss Parenterals Limited U85110GJ1997PLC031645 | Director | 15 Feb 2024 | 1997 | ₹232 Cr (FY 2023) | Active |
 Aprica Healthcare Limited U24232GJ2011PLC112374 | Director | 01 Oct 2017 | 2011 | ₹106 Cr (FY 2025) | Active |
| Eris Healthcare Private Limited U24211GJ2013PTC113419 | Director | 01 Dec 2017 | 2013 | ₹85.67 Cr (FY 2025) | Active |
 Eris M. J. Biopharm Private Limited U51397GJ2002PTC112851 | Director | 12 Dec 2016 | 2002 | ₹71.10 Cr (FY 2025) | Active |
 Eris Bionxt Private Limited U24299MP2020PTC051505 | Director | 13 Sep 2024 | 2020 | Active | |
| Talent Bridge Prosperity Foundation U88900GJ2026NPL173526 | Director | 13 Feb 2026 | 2026 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Eris Oaknet Healthcare Private Limited U74999GJ2011PTC145203 | Director | 12 May 2022 | 2011 | ₹253 Cr (FY 2023) | Active |
 Eris Therapeutics Private Limited U24230GJ2009PTC057670 | Director | 25 Nov 2009 | 2009 | Amalgamated | |
 Aprica Healthcare Limited U24290GJ2016PLC092903 | Director | 23 Jan 2019 | 2016 | ₹56.30 Cr (FY 2020) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Kaushal Kamlesh Shah
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kaushal Kamlesh Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kaushal Kamlesh Shah
Kaushal Kamlesh Shah currently holds 9 directorships: Eris Lifesciences Limited (Director, since 04 Aug 2020, revenue ₹5,069 Cr (FY 2025)); Eris Therapeutics Limited (Director, since 23 Jun 2021, revenue ₹771 Cr (FY 2025)); Swiss Parenterals Limited (Director, since 15 Feb 2024, revenue ₹232 Cr (FY 2023)); Aprica Healthcare Limited (Director, since 01 Oct 2017, revenue ₹106 Cr (FY 2025)); Eris Healthcare Private Limited (Director, since 01 Dec 2017, revenue ₹85.67 Cr (FY 2025)); and 4 more.
Kaushal Kamlesh Shah was first appointed on 25 Nov 2009 as Director at Eris Therapeutics Private Limited. The most recent appointment on record is 13 Feb 2026 at Talent Bridge Prosperity Foundation.
The 6 current companies of Kaushal Kamlesh Shah that report revenue have a combined latest revenue of ₹6,335 Cr: Eris Lifesciences Limited ₹5,069 Cr (FY 2025); Eris Therapeutics Limited ₹771 Cr (FY 2025); Swiss Parenterals Limited ₹232 Cr (FY 2023); Aprica Healthcare Limited ₹106 Cr (FY 2025); Eris Healthcare Private Limited ₹85.67 Cr (FY 2025); and 1 more.
Kaushal Kamlesh Shah held 3 earlier board appointments: Eris Oaknet Healthcare Private Limited (Director, 12 May 2022 to 22 Jun 2022); Eris Therapeutics Private Limited (Director, from 25 Nov 2009); Aprica Healthcare Limited (Director, from 23 Jan 2019).
The current boards of Kaushal Kamlesh Shah's companies include Amit Indubhushan Bakshi (Eris Lifesciences Limited), Inderjeet Singh Negi (Eris Lifesciences Limited), Kalpana Vasantrai Unadkat (Eris Lifesciences Limited), Milind Talegaonkar (Eris Lifesciences Limited), Prashant Gupta (Eris Lifesciences Limited), Sachin Shah (Eris Lifesciences Limited), among others.